Goldfinch Bio Obtains $55,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb993698-0292-4ca6-ad79-60afe8af9202 - Date
12/15/2016 - Company Name
Goldfinch Bio - Mailing Address
215 First Street 4th Floor Cambridge, MA 02142 USA - Company Description
At Goldfinch, we are pioneering a new approach to discover and develop therapeutics for kidney disease that is unprecedented. - Website
http://www.goldfinchbio.com - Transaction Type
Venture Equity - Transaction Amount
$55,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Third Rock Ventures
